<DOC>
	<DOCNO>NCT00377039</DOCNO>
	<brief_summary>This multicentre , randomize , double-blind , placebo control , parallel group exploratory study investigate efficacy , safety tolerability AD 337 treatment fibromyalgia female subject .</brief_summary>
	<brief_title>A Multicentre Trial Determine Efficacy Safety AD-337 Treatment Fibromyalgia</brief_title>
	<detailed_description />
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<criteria>Female Age 1865 Meet ACR 1990 criterion classification Fibromyalgia Able willing discontinue CNS active therapy If pain NOT primarily due Fibromyalgia Current prior history serious psychiatric disorder Pregnant/breastfeeding QTc &gt; 470ms Failure respond 2 adequate regime different class antidepressant .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>ACR 1990 Fibromyalgia</keyword>
	<keyword>Fibromyalgia Impact Questionnaire</keyword>
</DOC>